These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20103851)

  • 1. Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers.
    Inagaki Y; Xu H; Nakata M; Seyama Y; Hasegawa K; Sugawara Y; Tang W; Kokudo N
    Biosci Trends; 2009 Dec; 3(6):220-32. PubMed ID: 20103851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KL-6 mucin in metastatic liver cancer tissues from primary colorectal carcinoma.
    Zhang K; Tang W; Qu X; Guo Q; Inagaki Y; Seyama Y; Abe H; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Hepatogastroenterology; 2009; 56(93):960-3. PubMed ID: 19760920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of KL-6 mucin, a human MUC1 mucin, in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasion.
    Xu HL; Inagaki Y; Seyama Y; Sugawara Y; Kokudo N; Nakata M; Wang FS; Tang W
    Life Sci; 2009 Aug; 85(9-10):395-400. PubMed ID: 19631667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
    Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
    Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
    Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular localization of KL-6 mucin in colorectal carcinoma cell lines: association with metastatic potential and cell morphology.
    Guo Q; Tang W; Inagaki Y; Kokudo N; Sugawara Y; Karako H; Nakata M; Makuuchi M
    Oncol Rep; 2007 May; 17(5):1057-60. PubMed ID: 17390044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
    Tanaka M; Kitajima Y; Sato S; Miyazaki K
    Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
    Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
    Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma.
    Zhang W; Tang W; Inagaki Y; Qiu M; Xu HL; Li X; Sugawara Y; Nagawa H; Nakata M; Kokudo N
    Oncol Rep; 2008 Nov; 20(5):1013-9. PubMed ID: 18949395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.
    Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR
    J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma.
    Xu H; Inagaki Y; Tang W; Guo Q; Wang F; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Hepatogastroenterology; 2008; 55(88):2000-4. PubMed ID: 19260467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
    Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
    Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
    Yonezawa S; Nakamura A; Horinouchi M; Sato E
    J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
    Ichikawa T; Yamamoto T; Uenishi T; Tanaka H; Takemura S; Ogawa M; Tanaka S; Suehiro S; Hirohashi K; Kubo S
    J Hepatobiliary Pancreat Surg; 2006; 13(3):245-51. PubMed ID: 16708303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained aberrant localization of KL-6 mucin and beta-catenin at the invasion front of human gastric cancer cells.
    Inagaki Y; Tang W; Xu H; Nakata M; Mafune K; Konishi T; Seto Y; Kokudo N
    Anticancer Res; 2011 Feb; 31(2):535-42. PubMed ID: 21378335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
    Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
    Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
    Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study.
    Lau SK; Weiss LM; Chu PG
    Am J Clin Pathol; 2004 Jul; 122(1):61-9. PubMed ID: 15272531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
    Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.